CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-02 | Abdun-Nabi Daniel President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −21,906 | 0 | ||
| 2017-12-13 | Abdun-Nabi Daniel President & CEO | Exercise or conversion | +20,000 | $14.44 | $289K | 224,134 |
| 2017-12-13 | Abdun-Nabi Daniel President & CEO | Sale | −20,000 | $45.99 | $920K | 204,134 |
| 2017-12-13 | Abdun-Nabi Daniel President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 21,906 | ||
| 2017-12-12 | Richard Ronald Director | Exercise or conversion | +23,681 | $10.64 | $252K | 47,091 |
| 2017-12-12 | Richard Ronald Director | Sale | −23,681 | $45.02 | $1.1M | 23,410 |
| 2017-12-12 | Richard Ronald Director | Exercise or conversion · Employee Stock Option (Right to buy) | −23,681 | 0 | ||
| 2017-12-07 | Harsanyi Zsolt Director | Sale | −7,000 | $42.47 | $297K | 37,077 |
| 2017-11-29 | El-Hibri Fuad Chairman | Exercise or conversion | +27,983 | $22.03 | $616K | 1,558,199 |
| 2017-11-29 | El-Hibri Fuad Chairman | Sale | −27,983 | $42.08 | $1.2M | 1,530,216 |
| 2017-11-29 | El-Hibri Fuad Chairman | Exercise or conversion · Employee Stock Options (Right to Buy) | −27,983 | 0 | ||
| 2017-11-28 | El-Hibri Fuad Chairman | Exercise or conversion | +20,000 | $22.03 | $441K | 1,550,216 |
| 2017-11-28 | El-Hibri Fuad Chairman | Sale | −20,000 | $41.59 | $832K | 1,530,216 |
| 2017-11-28 | El-Hibri Fuad Chairman | Exercise or conversion · Employee Stock Options (Right to Buy) | −20,000 | 27,983 | ||
| 2017-11-14 | El-Hibri Fuad Chairman | Exercise or conversion | +20,000 | $22.03 | $441K | 1,550,216 |
| 2017-11-14 | El-Hibri Fuad Chairman | Sale | −20,000 | $40.05 | $801K | 1,530,216 |
| 2017-11-14 | El-Hibri Fuad Chairman | Exercise or conversion · Employee Stock Options (Right to Buy) | −20,000 | 47,983 | ||
| 2017-11-14 | El-Hibri Fuad Chairman | Sale | −20,000 | $40.05 | $801K | 1,490,216 |
| 2017-11-13 | El-Hibri Fuad Chairman | Exercise or conversion | +20,000 | $22.03 | $441K | 1,550,216 |
| 2017-11-13 | El-Hibri Fuad Chairman | Sale | −20,000 | $40.69 | $814K | 1,530,216 |
Page 42 of 45 · 887 trades